Cargando…
Anlotinib for refractory advanced non-small-cell lung cancer: A systematic review and meta-analysis
OBJECTIVE: To assess the efficacy and toxicity of anlotinib for the treatment of refractory advanced non-small-cell lung cancer (NSCLC). METHODS: We systematically searched databases for randomized controlled trials on anlotinib treatment for patients with advanced NSCLC published until November 6,...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7703897/ https://www.ncbi.nlm.nih.gov/pubmed/33253313 http://dx.doi.org/10.1371/journal.pone.0242982 |